The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in ...
Since its initial US approval in 2003, 200 million doses of FluMist have been distributed globally. The new ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...